These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36269746)

  • 41. Pain experiences among a population-based cohort of current, former, and never regular smokers with lung and colorectal cancer.
    Gonzalez A; Japuntich S; Keating NL; Wallace R; He Y; Streck JM; Park ER
    Cancer; 2014 Nov; 120(22):3554-61. PubMed ID: 25043285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Discussing Lung Cancer Screening with a Health Care Provider Among Current and Former Smokers in HINTS: A Secondary Data Analysis.
    Anderson SL; Livingston MD; Higgins KA; McBride CM
    Cancer Control; 2022; 29():10732748221130567. PubMed ID: 36171178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between inflammatory potential of diet and risk of lung cancer among smokers in a prospective study in Singapore.
    Shivappa N; Wang R; Hébert JR; Jin A; Koh WP; Yuan JM
    Eur J Nutr; 2019 Oct; 58(7):2755-2766. PubMed ID: 30255403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK.
    Cufari ME; Proli C; De Sousa P; Raubenheimer H; Al Sahaf M; Chavan H; Shedden L; Niwaz Z; Leung M; Nicholson AG; Anikin V; Beddow E; McGonigle N; Dusmet ME; Jordan S; Ladas G; Lim E
    Eur J Cancer; 2017 Oct; 84():55-59. PubMed ID: 28783541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychosocial response and symptom burden for male smokers with lung cancer.
    Niu ZM; Liang CS; Yu M; Wang YS; Yu HX; Zhang QW; Wei YQ
    Asian Pac J Cancer Prev; 2014; 15(1):309-14. PubMed ID: 24528047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of physical activity and lung cancer by histologic type in current, former, and never smokers.
    Leitzmann MF; Koebnick C; Abnet CC; Freedman ND; Park Y; Hollenbeck A; Ballard-Barbash R; Schatzkin A
    Am J Epidemiol; 2009 Mar; 169(5):542-53. PubMed ID: 19126591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model.
    Levitsky A; Pernemalm M; Bernhardson BM; Forshed J; Kölbeck K; Olin M; Henriksson R; Lehtiö J; Tishelman C; Eriksson LE
    Sci Rep; 2019 Nov; 9(1):16504. PubMed ID: 31712735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
    Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
    BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study.
    Du Y; Sidorenkov G; Groen HJM; Heuvelmans MA; Vliegenthart R; Dorrius MD; Timens W; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1442-1449. PubMed ID: 35534234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.
    Freedman ND; Leitzmann MF; Hollenbeck AR; Schatzkin A; Abnet CC
    Lancet Oncol; 2008 Jul; 9(7):649-56. PubMed ID: 18556244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk-stratified Approach for Never- and Ever-Smokers in Lung Cancer Screening: A Prospective Cohort Study in China.
    Wang F; Tan F; Shen S; Wu Z; Cao W; Yu Y; Dong X; Xia C; Tang W; Xu Y; Qin C; Zhu M; Li J; Yang Z; Zheng Y; Luo Z; Zhao L; Li J; Ren J; Shi J; Huang Y; Wu N; Shen H; Chen W; Li N; He J
    Am J Respir Crit Care Med; 2023 Jan; 207(1):77-88. PubMed ID: 35900139
    [No Abstract]   [Full Text] [Related]  

  • 54. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking.
    Reid A; de Klerk NH; Ambrosini GL; Berry G; Musk AW
    Occup Environ Med; 2006 Aug; 63(8):509-12. PubMed ID: 16849527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attending community-based lung cancer screening influences smoking behaviour in deprived populations.
    Balata H; Traverse-Healy L; Blandin-Knight S; Armitage C; Barber P; Colligan D; Elton P; Kirwan M; Lyons J; McWilliams L; Novasio J; Sharman A; Slevin K; Taylor S; Tonge J; Waplington S; Yorke J; Evison M; Booton R; Crosbie PAJ
    Lung Cancer; 2020 Jan; 139():41-46. PubMed ID: 31726252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
    Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
    Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 58. Lung cancer screening: review and performance comparison under different risk scenarios.
    Tota JE; Ramanakumar AV; Franco EL
    Lung; 2014 Feb; 192(1):55-63. PubMed ID: 24153450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.
    Ripley RT; McMillan RR; Sima CS; Hasan SM; Ahmad U; Lou F; Jones DR; Rusch VW; Rizk NP; Huang J
    Ann Thorac Surg; 2014 Sep; 98(3):968-74. PubMed ID: 25038021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer.
    Convill J; Blackhall F; Yorke J; Faivre-Finn C; Gomes F
    Oncol Ther; 2022 Dec; 10(2):481-491. PubMed ID: 36223028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.